152 related articles for article (PubMed ID: 37623837)
1. Metabolites Potentially Derived from Gut Microbiota Associated with Podocyte, Proximal Tubule, and Renal and Cerebrovascular Endothelial Damage in Early Diabetic Kidney Disease in T2DM Patients.
Balint L; Socaciu C; Socaciu AI; Vlad A; Gadalean F; Bob F; Milas O; Cretu OM; Suteanu-Simulescu A; Glavan M; Ienciu S; Mogos M; Jianu DC; Ursoniu S; Dumitrascu V; Vlad D; Popescu R; Petrica L
Metabolites; 2023 Jul; 13(8):. PubMed ID: 37623837
[TBL] [Abstract][Full Text] [Related]
2. Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients.
Balint L; Socaciu C; Socaciu AI; Vlad A; Gadalean F; Bob F; Milas O; Cretu OM; Suteanu-Simulescu A; Glavan M; Ienciu S; Mogos M; Jianu DC; Petrica L
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509122
[TBL] [Abstract][Full Text] [Related]
3. Metabolite Profiling of the Gut-Renal-Cerebral Axis Reveals a Particular Pattern in Early Diabetic Kidney Disease in T2DM Patients.
Balint L; Socaciu C; Socaciu AI; Vlad A; Gadalean F; Bob F; Milas O; Cretu OM; Suteanu-Simulescu A; Glavan M; Ienciu S; Mogos M; Jianu DC; Petrica L
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047187
[TBL] [Abstract][Full Text] [Related]
4. Pro-inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients.
Milas O; Gadalean F; Vlad A; Dumitrascu V; Velciov S; Gluhovschi C; Bob F; Popescu R; Ursoniu S; Jianu DC; Matusz P; Pusztai AM; Secara A; Simulescu A; Stefan M; Patruica M; Petrica F; Vlad D; Petrica L
J Diabetes Complications; 2020 Feb; 34(2):107479. PubMed ID: 31806428
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria.
Winther SA; Henriksen P; Vogt JK; Hansen TH; Ahonen L; Suvitaival T; Hein Zobel E; Frimodt-Møller M; Hansen TW; Hansen T; Parving HH; Legido-Quigley C; Rossing P; Pedersen O
Diabetologia; 2020 Dec; 63(12):2713-2724. PubMed ID: 32886190
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial DNA Changes in Blood and Urine Display a Specific Signature in Relation to Inflammation in Normoalbuminuric Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients.
Petrica L; Vlad A; Gadalean F; Muntean DM; Vlad D; Dumitrascu V; Bob F; Milas O; Suteanu-Simulescu A; Glavan M; Jianu DC; Ursoniu S; Balint L; Mogos-Stefan M; Ienciu S; Cretu OM; Popescu R
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372951
[TBL] [Abstract][Full Text] [Related]
7. Podocyturia parallels proximal tubule dysfunction in type 2 diabetes mellitus patients independently of albuminuria and renal function decline: A cross-sectional study.
Petrica L; Vlad M; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Popescu R; Gluhovschi C; Matusz P; Velciov S; Bob F; Ursoniu S; Vlad D
J Diabetes Complications; 2017 Sep; 31(9):1444-1450. PubMed ID: 28161386
[TBL] [Abstract][Full Text] [Related]
8. Urinary podocyte-associated mRNA levels correlate with proximal tubule dysfunction in early diabetic nephropathy of type 2 diabetes mellitus.
Petrica L; Ursoniu S; Gadalean F; Vlad A; Gluhovschi G; Dumitrascu V; Vlad D; Gluhovschi C; Velciov S; Bob F; Matusz P; Milas O; Secara A; Simulescu A; Popescu R
Diabetol Metab Syndr; 2017; 9():31. PubMed ID: 28484521
[TBL] [Abstract][Full Text] [Related]
9. The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease.
Zhang Q; Zhang Y; Zeng L; Chen G; Zhang L; Liu M; Sheng H; Hu X; Su J; Zhang D; Lu F; Liu X; Zhang L
Front Pharmacol; 2021; 12():757508. PubMed ID: 34899312
[No Abstract] [Full Text] [Related]
10. Serum zonulin levels in type 2 diabetes patients with diabetic kidney disease.
Sirin FB; Korkmaz H; Eroglu I; Afsar B; Kumbul Doguc D
Endokrynol Pol; 2021; 72(5):545-549. PubMed ID: 34057189
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease.
Xu X; Dong Y; Liu M; Li Y; Zhang Y
Nefrologia (Engl Ed); 2021; 41(5):548-555. PubMed ID: 36165137
[TBL] [Abstract][Full Text] [Related]
12. Urine transferrin as an early endothelial dysfunction marker in type 2 diabetic patients without nephropathy: a case control study.
Sánchez-Hidalgo JJ; Suárez-Cuenca JA; Lozano-Nuevo JJ; García-López VH; Leal-Gutiérrez MG; León-Angel SA; Ramírez-Villa ML; Rodea-Rubio ME; González-Hernández JE; Canela-Mayoral JA; Murillo-Heredia E; Vera-Gómez E; Hernández-Patricio A; Zamora-Alemán CR; Domínguez-Pérez GA; Gutiérrez-Buendia JA; Mondragón-Terán P
Diabetol Metab Syndr; 2021 Nov; 13(1):128. PubMed ID: 34743740
[TBL] [Abstract][Full Text] [Related]
13. Serum L C3-II levels in type 2 diabetic patients with impaired renal functions.
Ahmed Salıh Gezh S; Deveci K; Sivgin H; Guzelgul F
Cytokine; 2024 Jun; 181():156683. PubMed ID: 38943738
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes.
Wang Z; Tang J; Jin E; Ren C; Li S; Zhang L; Zhong Y; Cao Y; Wang J; Zhou W; Zhao M; Huang L; Qu J
Front Endocrinol (Lausanne); 2022; 13():986303. PubMed ID: 36157454
[TBL] [Abstract][Full Text] [Related]
15. Deregulated profiles of urinary microRNAs may explain podocyte injury and proximal tubule dysfunction in normoalbuminuric patients with type 2 diabetes mellitus.
Milas O; Gadalean F; Vlad A; Dumitrascu V; Gluhovschi C; Gluhovschi G; Velciov S; Popescu R; Bob F; Matusz P; Pusztai AM; Cretu OM; Secara A; Simulescu A; Ursoniu S; Vlad D; Petrica L
J Investig Med; 2018 Apr; 66(4):747-754. PubMed ID: 29279420
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease.
Ren X; Wang W; Cao H; Shao F
Front Endocrinol (Lausanne); 2023; 14():1180338. PubMed ID: 37305031
[TBL] [Abstract][Full Text] [Related]
17. Urinary microbiota and serum metabolite analysis in patients with diabetic kidney disease.
Yang Y; Ma C; Li S; Cai W; Dai W; Zhang X; Yin L; Donge Tang ; Liu F; Dai Y
Heliyon; 2023 Aug; 9(8):e17040. PubMed ID: 37521000
[TBL] [Abstract][Full Text] [Related]
18. Urine metabolomics reveals biomarkers and the underlying pathogenesis of diabetic kidney disease.
Luo M; Zhang Z; Lu Y; Feng W; Wu H; Fan L; Guan B; Dai Y; Tang D; Dong X; Yun C; Hocher B; Liu H; Li Q; Yin L
Int Urol Nephrol; 2023 Apr; 55(4):1001-1013. PubMed ID: 36255506
[TBL] [Abstract][Full Text] [Related]
19. Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.
Pena MJ; Lambers Heerspink HJ; Hellemons ME; Friedrich T; Dallmann G; Lajer M; Bakker SJ; Gansevoort RT; Rossing P; de Zeeuw D; Roscioni SS
Diabet Med; 2014 Sep; 31(9):1138-47. PubMed ID: 24661264
[TBL] [Abstract][Full Text] [Related]
20. MiRNA Expression is Associated with Clinical Variables Related to Vascular Remodeling in the Kidney and the Brain in Type 2 Diabetes Mellitus Patients.
Petrica L; Pusztai AM; Vlad M; Vlad A; Gadalean F; Dumitrascu V; Vlad D; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Petrica M; Matusz P; Cretu O; Radu D; Milas O; Secara A; Simulescu A; Popescu R; Jianu DC
Endocr Res; 2020; 45(2):119-130. PubMed ID: 31724439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
